Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVERRICA PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VRCA - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ -17.48M | $ 64.42M | 0 |
| 3/31/2025 | $ -18.58M | $ 50.87M | 0 |
| 12/31/2024 | $ -9.86M | $ 59.49M | 0 |
| 9/30/2024 | $ -34.05M | $ 36.37M | 0 |
| 6/30/2024 | $ -13.3M | $ 133.13M | 0 |
| 3/31/2024 | $ 1.51M | $ 405.54M | 268.92 |
| 12/31/2023 | $ 19.76M | $ 223.55M | 11.31 |
| 9/30/2023 | $ 42.3M | $ 135.03M | 3.19 |
| 6/30/2023 | $ 55.4M | $ 222.52M | 4.02 |
| 3/31/2023 | $ 64.85M | $ 274.4M | 4.23 |
Key Performance Insights, Last 5 Years
- VERRICA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 5.18.
- Over the past 5 years, VERRICA PHARMACEUTICALS INC's average P/B has been 24.15.
- The median P/B for VERRICA PHARMACEUTICALS INC during this period was 6.58
- VERRICA PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 268.92.
- The lowest P/B recorded by VERRICA PHARMACEUTICALS INC in the same timeframe 2.18
VERRICA PHARMACEUTICALS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for VERRICA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 202.79M ] / Equity [ $ 39.18M ]
(=) P/B [ 5.18 ] VRCA - Price to Book, Last 5 years
2.18
Minimum
Sep 30, 2022
268.92
Maximum
Mar 31, 2024
24.15
Average
6.58
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |